Summary by Futu AI
On June 12, 2024, Margaret G. McGlynn, reported a completed transaction involving the acquisition of 6,670 shares of Novavax Inc (NVAX) common stock at a price of $0.00 per share. This transaction was categorized as an exercise or conversion of derivative security, conducted directly by McGlynn. Following this transaction, McGlynn's direct holdings in Novavax increased to a total of 10,470 shares. The transaction reflects a significant investment in the company by McGlynn, and it may indicate confidence in the future performance of Novavax.